Expecting A Lot Of Missing Data In Your Resource Use Questionnaire? Give Patients A Resource Use Log Too!

Published Jan 17, 2013
Bristol, UK - Using patient-completed questionnaires to collect resource use in economic evaluations conducted alongside randomised controlled trials (RCTs) often results in missing data. A research team from the University of Bristol designed a log to give patients at baseline so they could record their resource use as it happens and help them complete resource use questions at follow-up. The article, “Using resource use logs to reduce the amount of missing data in economic evaluations alongside trials,” published in Value in Health, describes the full details of how the log was evaluated through a trial, where patients were randomised to be given or not given the log, and a qualitative study to explore patients’ views about using it. The log was well-received by patients and is useful in reducing missing data for some types of resource use collected by resource use questionnaires. Dr. Sian Noble, co-author on the study, says, Missing data is an often overlooked issue in economic evaluations alongside randomised controlled trials. The resource use log is a practical way of helping study participants complete follow-up questionnaires which has the potential of reducing missing data at a minimum patient burden.”

Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research as well as policy papers to help health care leaders make evidence-based decisions. The journal is published bi-monthly and has over 8,000 subscribers (clinicians, decision makers, and researchers worldwide).

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health.

For more information: www.ispor.org

Related Stories

The Ozempic Paradox: How Spending Billions on Weight-Loss Drug Would Actually Reduce Overall Medicare Costs

Oct 14, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a landmark study by researchers at the University of Washington, Curta, Inc, and the University of North Carolina showing that broad Medicare coverage of semaglutide in diabetes, obesity, and liver disease could generate significant cost savings while delivering substantial health benefits to beneficiaries. The report, “Comprehensive Access to Semaglutide: Clinical and Economic Implications for Medicare,” was published in the October 2025 issue of Value in Health.

ISPOR Launches New Content on Whole Health

Sep 23, 2025

ISPOR announced that it has launched new website content on whole health, a topic of increasing importance as health systems across the globe grapple with providing the best possible healthcare to patients within constrained budgets.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×